Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTP0302 vs Conventional OST for Bowel Preparation
NCT06287606Phase 3Completed
- Sponsor
- Taejoon Pharmaceutical Co., Ltd.
- Start
- Aug 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of CTP0302-B in bowel preparation, sponsored by Taejoon Pharmaceutical Co., Ltd.. Started Aug 2023; status: completed.
02
Drugs
CTP0302-B
03
Conditions
bowel preparation
Beyond the preview
Go deeper on NCT06287606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06287606.